Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

8.965
+0.2953.40%
Volume:3.07M
Turnover:27.24M
Market Cap:8.69B
PE:-74.71
High:9.385
Open:8.780
Low:8.400
Close:8.670
52wk High:15.750
52wk Low:6.230
Shares:969.00M
HK Float Shares:969.00M
Volume Ratio:1.85
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.120
ROE:-6.43%
ROA:-4.42%
PB:4.35
PE(LYR):-74.71
PS:13.15

Loading ...

Hong Kong Market Preview: US May CPI Rises 4.2% Year-on-Year; MIIT to Boost R&D for High-End Optoelectronic Chips

Stock News
·
Jun 11

BRIEF-Alphamab Oncology Says Phase III Clinical Study Of Anbenitamab Met Primary Endpoint

Reuters
·
Jun 10

Alphamab-B's Phase III Trial for KN026 in First-Line HER2-Positive Advanced Breast Cancer Hits Primary Endpoint

Stock News
·
Jun 10

Alphamab: Anbenitamab Phase III Trial Hits Primary Endpoint in First-Line HER2-Positive Advanced Breast Cancer

Bulletin Express
·
Jun 10

Alphamab Oncology says phase III trial of Anbenitamab plus albumin-bound docetaxel meets primary endpoint in first-line HER2+ advanced breast cancer

Reuters
·
Jun 10

Alphamab Oncology - Phase Iii Clinical Study of Anbenitamab (Kn026) as First-Line Treatment for Her2+ Advanced Breast Cancer Met Primary Endpoint

THOMSON REUTERS
·
Jun 10

HK Movers | Biotech Stocks Jump. Asymchem up Nearly 7%; SKB Bio up About 6%; Hengrui Pharma, Pharmaron, InnoGen up over 4%; Wuxi Apptec up 3%; Laekna, Joinn, Remegen up over 2%

Tiger Newspress
·
Jun 05

BRIEF-Alphamab Oncology Says CEO Buys 554,000 Shares On June 4

Reuters
·
Jun 05

ALPHAMAB-B Announces Share Purchases by Executive Director and Management

Deep News
·
Jun 05

Alphamab-B Executes Share Buyback, Spending HK$1.11 Million

Stock News
·
Jun 05

Alphamab Oncology: CEO Xu Ting Leads HK$4.99 Million Share Purchase; Post-Deal Stake Rises to 32.4%

Bulletin Express
·
Jun 05

Alphamab Oncology - CEO DR. Xu Ting Purchases 554,000 Shares on Open Market on June 4, 2026

THOMSON REUTERS
·
Jun 05

Alphamab Oncology - Aggregate Consideration for Share Purchases Totals HK$4.99 Mln at HK$7.375 per Share

THOMSON REUTERS
·
Jun 05

Alphamab Oncology Issues 88,000 New Shares in May; Total Issued Shares Reach 974.38 Million

Bulletin Express
·
Jun 04

Alphamab Oncology unveils favourable Phase I data for dual-target ADC JSKN016 in HER2- breast cancer at ASCO 2026

Bulletin Express
·
Jun 02

Alphamab Oncology presents Phase I ASCO data for JSKN016 in HER2-negative metastatic breast cancer

Reuters
·
Jun 02

BRIEF-Alphamab Oncology Says Phase III KN026-004 Study Enrolls 521 Patients And Meets Primary Endpoint

Reuters
·
Jun 01

Alphamab-B's KN026 Phase III Trial Data for HER2+ Breast Cancer Neoadjuvant Therapy Presented as Late-Breaking Oral at 2026 ASCO

Stock News
·
Jun 01

Alphamab Oncology - Phase Iii Kn026-004 Study Enrolls 521 Patients and Meets Primary Endpoint

THOMSON REUTERS
·
Jun 01

National Medical Insurance Catalog Adjustment Plan for 2026 Released; MOBVISTA (01860) Q1 Revenue Climbs 32.2%

Stock News
·
Jun 01